Intravitreal Bevacizumab for Low Vision in Neovascular Age-related Macular Degeneration (AMD)
Condition(s):Age Related Macular DegenerationLast Updated:April 1, 2011Completed
Hide Studies Not Open or Pending
Condition(s):Age Related Macular DegenerationLast Updated:April 1, 2011Completed
Condition(s):Age-related Macular Degeneration; Coronary Artery Disease; Cardiovascular DiseasesLast Updated:September 12, 2019Unknown status
Condition(s):Neovascular Age-related Macular Degeneration (nAMD)Last Updated:November 13, 2023Recruiting
Condition(s):Neovascular Age-related Macular Degeneration; Diabetic Macular EdemaLast Updated:February 13, 2023Recruiting
Condition(s):Wet Age-related Macular DegenerationLast Updated:May 30, 2023Completed
Condition(s):Age-Related Macular DegenerationLast Updated:July 20, 2010Completed
Condition(s):Early to Moderate Dry Age-Related Macular DegenerationLast Updated:September 11, 2023Recruiting
Condition(s):Age-related Macular Degeneration (AMD)Last Updated:January 8, 2024Not yet recruiting
Condition(s):Neovascular Age-related Macular DegenerationLast Updated:December 6, 2018Completed
Condition(s):Age-related Macular DegenerationLast Updated:May 19, 2020Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.